← Back to all trials
Active Not Recruiting
NCT03729453
Intra-operative Pancreatoscopy in Patients With IPMN
Conditions: Intraductal Papillary Mucinous Neoplasm
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: Boston Scientific Corporation
Location: University of Colorado Hospital Denver Colorado
Summary
To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.
Eligibility Criteria
Inclusion Criteria:
1. Patient scheduled for surgery for suspected MD-IPMN or Mixed IPMN within 4-6 weeks of enrollment
2. Diameter of pancreatic main duct \>5mm on pre-operative MRI or CT
3. Written informed consent from patient to participate in the study, including compliance with study procedures
Exclusion Criteria:
1. Contraindication for pancreatoscopy
2. Age: less than 18 years
3. Pregnant women, evaluated per local clinical standard
Source: ClinicalTrials.gov (NCT03729453). StuddyBuddy aggregates publicly available trial information.
